Emerging multiple sclerosis disease-modifying therapies
PS Giacomini, PJ Darlington… - Current opinion in …, 2009 - journals.lww.com
Several of the emerging therapies focusing on immune-mediated disease mechanisms
seem to offer stronger efficacy than the currently approved immune modulators for MS …
seem to offer stronger efficacy than the currently approved immune modulators for MS …
Emerging multiple sclerosis disease-modifying therapies.
PS Giacomini, PJ Darlington, A Bar-Or - Current Opinion in …, 2009 - europepmc.org
Several of the emerging therapies focusing on immune-mediated disease mechanisms
seem to offer stronger efficacy than the currently approved immune modulators for MS …
seem to offer stronger efficacy than the currently approved immune modulators for MS …
Emerging multiple sclerosis disease-modifying therapies
PS Giacomini, PJ Darlington… - Current Opinion in …, 2009 - journals.lww.com
Several of the emerging therapies focusing on immune-mediated disease mechanisms
seem to offer stronger efficacy than the currently approved immune modulators for MS …
seem to offer stronger efficacy than the currently approved immune modulators for MS …
Emerging multiple sclerosis disease-modifying therapies
PS Giacomini, PJ Darlington… - Current opinion in …, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose of review We focus on emerging therapies for the treatment of multiple sclerosis
(MS) whose progress through late-phase clinical trials has furthered our understanding of …
(MS) whose progress through late-phase clinical trials has furthered our understanding of …